Dry Eyes (Keratoconjunctivitis Sicca) – A Complete Medical Guide

Overview

Dry eye disease (DED), also called **keratoconjunctivitis sicca**, is a chronic condition characterized by insufficient tear production, excessive tear evaporation, or poor tear quality, leading to ocular surface inflammation and discomfort. The tear film normally covers the front of the eye, providing lubrication, nutrients, and a smooth optical surface. When this film becomes unstable, the eye becomes dry, irritated, and vulnerable to infection.

Globally, dry eye affects an estimated 5‑35% of adults depending on the definition used and the population studied. In the United States, the **American Academy of Ophthalmology** estimates that more than 16 million adults have clinically significant dry eye, a number that rises sharply after age 50. Women are 2–3 times more likely than men to develop the condition, partly because of hormonal influences.¹

Symptoms

Symptoms can be mild and intermittent or severe and constant. They often worsen in environments with low humidity, wind, or prolonged visual tasks (e.g., computer work). Common complaints include:

• Foreign‑body sensation – feeling that something is in the eye.
• Burning or stinging – often described as “raw” eyes.
• Itching – may be confused with allergic conjunctivitis.
• Grittiness or sand‑like feeling.
• Redness – especially along the sclera.
• Blurry vision – usually improves after blinking.
• Excessive tearing – paradoxical reflex tearing caused by ocular irritation.
• Difficulty wearing contact lenses or intolerance to them.
• Eye fatigue after reading or screen use.
• Morning crusting or “sleepy eyes” that clear after blinking.

Causes and Risk Factors

The pathophysiology of dry eye is multifactorial and is broadly divided into two mechanisms: aqueous‑deficient and evaporative. Many patients have a combination of both.

Aqueous‑deficient Dry Eye

• Age‑related lacrimal gland decline – natural reduction in tear production.
• Autoimmune diseases – most notably Sjögren’s syndrome, rheumatoid arthritis, systemic lupus erythematosus, and thyroid eye disease.
• Medications – antihistamines, decongestants, antidepressants, anticholinergics, beta‑blockers, and certain chemotherapy agents.
• Lacrimal gland damage – from radiation therapy or ocular surgery.

Evaporative Dry Eye

• Meibomian gland dysfunction (MGD) – obstructed or abnormal lipid secretion.
• Environmental factors – low humidity, wind, air‑conditioning, or heating.
• Screen time – reduced blink rate during prolonged digital device use.
• Contact lens wear – especially low‑oxygen (hydrogel) lenses.
• Blepharitis – inflammation of the eyelid margins that interferes with tear spread.

Additional Risk Factors

• Female sex (especially post‑menopausal)
• Age > 50 years
• Smoking
• History of ocular surgery (LASIK, cataract extraction)
• Systemic diseases that affect nerves (e.g., diabetes, Parkinson’s)

Diagnosis

Diagnosing dry eye involves a combination of patient history, clinical examination, and objective tests. The goal is to confirm tear‑film deficiency, classify the type, and assess severity.

Clinical History

• Onset, duration, and pattern of symptoms.
• Medication list and systemic disease review.
• Environmental and occupational exposures.
• Contact lens use and visual‑task habits.

Ophthalmic Examination

• Slit‑lamp biomicroscopy – evaluates lid margins, Meibomian glands, conjunctiva, and corneal staining.
• Fluorescein or Lissamine Green staining – highlights areas of epithelial damage; graded using the Oxford or NEI scales.
• Tear Break‑Up Time (TBUT) – a drop of fluorescein is placed; a time <10 seconds suggests instability.
• Schirmer test – filter paper placed under the lower eyelid for 5 minutes; <5 mm wetting indicates aqueous deficiency.
• Meibography – infrared imaging of Meibomian glands (optional but useful for MGD).

Additional Tests (when indicated)

• Ocular Surface Disease Index (OSDI) questionnaire – quantifies symptom severity.
• Tear osmolarity measurement – >308 mOsm/L is consistent with dry eye.
• Inflammatory biomarkers (e.g., matrix metalloproteinase‑9) via point‑of‑care kits.
• Serologic testing for Sjögren’s (anti‑SSA/Ro, anti‑SSB/La) if autoimmune etiology suspected.

Treatment Options

Treatment is individualized based on severity, underlying cause, and patient preference. A step‑wise approach—from lubricants to prescription medications and procedural interventions—helps restore tear film stability and reduce inflammation.

1. Lifestyle & Environmental Modifications

• Increase ambient humidity (humidifiers, especially in winter).
• Take regular “blink breaks” during screen work – 20‑20‑20 rule (every 20 min, look 20 ft away for 20 s).
• Avoid direct air flow from fans, vents, or hair dryers.
• Stay hydrated; limit caffeine and alcohol.
• Wear wrap‑around sunglasses outdoors to reduce wind‑induced evaporation.

2. Over‑the‑Counter (OTC) Lubricants

• Artificial tears – preservative‑free options are preferred for frequent use. Formulations include:
  • Polyethylene glycol / propylene glycol (e.g., Systane Ultra)
  • Carboxymethylcellulose (e.g., Refresh)
  • Hydroxypropyl guar (e.g., Blink Tears)
• Ointments or gels – for nighttime use; thicker consistency reduces evaporation.
• Lipids‑containing drops – restore the tear‑film lipid layer (e.g., Refresh Optive‑Alk).

3. Prescription Medications

• Ciclosporin 0.05% ophthalmic emulsion (Restasis) – immunomodulatory; improves tear production over 3‑6 months.²
• Lifitegrast 5% ophthalmic solution (Xiidra) – blocks LFA‑1/ICAM‑1 interaction, reducing ocular surface inflammation.
• Topical corticosteroids – short‑term use for acute inflammation; monitor intra‑ocular pressure.
• Oral tetracyclines (doxycycline) or macrolides (azithromycin) – for Meibomian gland dysfunction, because of anti‑inflammatory and anti‑bacterial properties.
• Autologous serum eye drops – for severe refractory cases; contain growth factors and cytokines similar to natural tears.

4. Procedural & Device‑Based Therapies

• Punctal plugs – silicone or collagen devices inserted into tear drainage canals to retain tears; can be temporary (3‑6 months) or permanent.
• Thermal pulsation (LipiFlow) – applies heat and pressure to unclog Meibomian glands.
• Intense pulsed light (IPL) therapy – reduces Meibomian gland inflammation and abnormal vessels.
• Meibomian gland expression – manual massage performed by an eye‑care professional.
• Amniotic membrane or platelet‑rich plasma drops – emerging options for ocular surface healing.

5. Managing Underlying Systemic Disease

If an autoimmune disorder such as Sjögren’s syndrome is identified, collaboration with a rheumatologist is essential. Systemic agents (hydroxychloroquine, pilocarpine, or secretagogues) may improve overall tear production.

Living with Dry Eyes (keratoconjunctivitis sicca)

Effective self‑care can dramatically improve comfort and visual function.

Daily Management Checklist

1. Morning routine: Apply preservative‑free artificial tears before makeup; use a warm compress (5–10 minutes) to melt Meibomian gland secretions.
2. Throughout the day: Keep a small bottle of lubricating drops at your desk; reapply every 2–4 hours as needed.
3. Screen work: Follow the 20‑20‑20 rule; consciously blink fully.
4. Evening routine: Apply ointment or gel before bed; consider a second punctal plug if symptoms persist.
5. Eye hygiene: Gently clean eyelid margins with diluted baby shampoo or commercially available lid scrubs; do this once daily.
6. Nutrition: Incorporate omega‑3 fatty acids (fish oil, flaxseed) – 1000 mg EPA/DHA daily has shown modest benefit in clinical trials.³
7. Follow‑up: Schedule ophthalmology visits every 6–12 months, or sooner if symptoms change.

Adapting Work and Home Environments

• Use a humidifier in dry climates or heated indoor spaces.
• Position computer monitors slightly below eye level to encourage complete blinking.
• Wear a protective eyewear (wrap‑around glasses) during windy outdoor activities.
• Avoid smoke‑filled areas; both tobacco and incense exacerbate tear evaporation.

Prevention

While some risk factors (age, genetics) are unavoidable, many preventive steps can lower the likelihood of developing significant dry eye or worsening existing disease.

• Maintain adequate hydration—drink 8‑10 glasses of water daily.
• Limit exposure to air‑conditioning or heating vents directly aimed at the face.
• Take regular breaks during prolonged visual tasks; consciously blink.
• Choose preservative‑free eye drops if you use lubricants more than 4 times daily.
• Adopt a balanced diet rich in omega‑3 fatty acids and antioxidants (vitamin A, lutein).
• Quit smoking and avoid secondhand smoke.
• Review medications with your physician; many systemic drugs can exacerbate dryness.
• Use protective eyewear when swimming in chlorinated pools or during hazardous work.

Complications

If untreated, chronic dry eye can lead to serious ocular problems:

• Corneal epithelial defects – persistent abrasions that may become ulcerated.
• Infectious keratitis – bacterial, viral, or fungal infection due to compromised surface.
• Scarring and neovascularization – can impair visual acuity.
• Reduced quality of life – chronic pain, difficulty working, and psychosocial stress.
• Contact lens intolerance – leading to discontinuation of lenses.

When to Seek Emergency Care

References:

1. Mayo Clinic. Dry Eyes – Symptoms and Causes. Accessed May 2026.
2. U.S. Centers for Disease Control and Prevention. Dry Eye Disease. Updated 2023.
3. Cleveland Clinic. Dry Eye Syndrome. Reviewed 2022.
4. American Academy of Ophthalmology. What is Dry Eye? 2024.
5. World Health Organization. Eye Health – Dry Eye. 2023.